Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Personalized mRNA Tumor Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Squamous Carcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma and Colorectal Adenocarcinoma

NCT03468244 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT03468244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03468244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Personalized mRNA Tumor Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Squamous Carcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma and Colorectal Adenocarcinoma
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2018
Completion date
December 31, 2021
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced esophageal squamous carcinoma, colorectal adenocarcinoma, gastric adenocarcinoma, pancreatic adenocarcinoma